Digital Health Startups

Cellestial Health is a preclinical-stage biotech developing therapies for Parkinson's disease, with a lead candidate rooted in astrocytic network biology. The company focuses on drug discovery for neurological disease.

1 investor

CellMax Life appears to be a diagnostics company, though the page provided only contains a biography of John Sninsky (Chief Scientific Officer) with no explicit company description, products, or business model stated.

1 investor

Cellworks develops AI-driven mechanistic biology models that simulate how an individual patient will respond to drug therapies by combining molecular modeling, clinical guidelines, and over 300 million patient records. It serves biopharma drug development teams and physicians with applications across precision oncology, population health, and care delivery.

1 investor

Celo is a secure messaging and collaboration platform for healthcare care teams, available on iPhone, Android, and web. It is used by healthcare organizations and individuals to communicate while safeguarding patient data.

1 investor

Cenote offers AI sales agents that contact direct-to-consumer online shoppers via phone and text to guide purchase decisions and recover abandoned transactions. The service addresses conversion gaps in e-commerce by maintaining ongoing conversations with potential buyers across multiple channels.

1 investor

CenterPointe Hospital provides inpatient, residential, and outpatient behavioral healthcare for adults and senior adults dealing with mental health conditions and substance use disorders. It is located in St. Charles, Missouri.

1 investor

Central da Visão is a Brazilian scheduling service that connects patients needing eye surgery with vetted ophthalmology clinics offering accessible pricing and payment options. It focuses on surgical patients without health insurance, accompanying them from first contact through post-operative care across 12 states and more than 30 cities in Brazil.

1 investor

CentralReach provides AI-powered software for autism and intellectual/developmental disability (IDD) care, serving applied behavior analysis practices, multidisciplinary clinics, and special education programs. The platform tech-enables care delivery across ABA, speech therapy, occupational therapy, and related services.

1 investor

The Centre for Digital Media is an educational institution that collaborates with founding academic partners, industry, and community organizations to deliver digital media programming focused on addressing societal challenges. Based in Vancouver's Creative District, it emphasizes innovation, social impact, and inclusive learning aligned with digital futures and industry workforce needs.

1 investor

Cerebra develops technology focused on stroke, addressing both ischemic and hemorrhagic types of the condition. The available page content describes stroke mechanisms but provides limited detail about the company's specific product or service.

1 investor

Cerebriu develops machine learning software for medical imaging, applying AI to healthcare diagnostics. The company operates in the MedTech space with commercial activity across Europe and the US.

1 investor

Ceresti provides support and resources for family caregivers of people living with dementia to improve care outcomes and reduce healthcare costs.

1 investor

Cerevanta provides AI-powered analysis of brain imaging to help neurologists make clinical decisions more effectively. The platform targets neurology care providers to reduce diagnostic delays and improve patient outcomes.

1 investor

CereVu Medical develops an AI-driven wearable sensor that continuously monitors vital signs and detects biomarkers for pain and dyspnea, designed for use by healthcare providers and clinical settings.

1 investor

Cerora develops a healthcare platform that integrates small biosensors to capture multimodal signatures of brain health, including EEG, cognitive, and voice-based data. Its devices are intended to aid clinicians in the evaluation, diagnosis, and management of brain disorders, injuries, and diseases.

1 investor

CertaScan provides a digital newborn footprinting system that scans and stores infants' footprints, with optional security photos and the mother's fingerprint, for reliable baby identification in hospitals. Its system combines scanning hardware, patented software, and services (installation, training, maintenance) for hospitals and integrates with electronic medical records, serving the U.S. maternity and infant-safety market.

1 investor

Certico provides healthcare planning and nurse-led telephone advisory services, using licensed nurses to give medical guidance and booking doctor appointments through a nationwide network of private healthcare providers across specialties. It serves patients seeking care coordination in Sweden.

1 investor

CERTIFY Health offers a unified medical practice software platform that integrates patient experience, practice management, documentation, revenue cycle, and interoperability workflows for healthcare providers. The platform serves medical practices seeking to streamline operations, improve patient journeys, and ensure regulatory compliance.

1 investor

Certintell delivers remote clinical support for chronic and behavioral health conditions to community pharmacies and health centers through telehealth, patient outreach, care coordination, and clinician collaboration. The platform provides care management and remote patient monitoring services without requiring additional full-time hires or upfront equipment costs.

1 investor

Certuma builds autonomous clinical infrastructure that combines LLM reasoning with deterministic verification to deliver physician-reviewed clinical decisions at scale, addressing the global physician shortage by validating clinical workflows as infrastructure for remote patient care.

1 investor

Cerulea Clinical Trials runs ophthalmic clinical trials focused on vision research, giving patients access to new therapies and clinical care. It also offers CeruleaCONNECT, a program that keeps healthcare practitioners informed about recruiting and upcoming eye-related trials so they can refer eligible patients.

1 investor

Cumberland Emerging Technologies provides development partnerships with researchers and companies to advance early-stage biomedical technologies toward commercialization, and operates a life sciences incubator facility in Nashville offering laboratory space and support services to pharmaceutical, medical device, and diagnostics firms.

1 investor

CGenetix develops liquid biopsy biomarkers using circulating cell-free DNA to detect organ damage, with a focus on transplantation (kidney, lung, pancreas) rejection diagnostics. The company applies techniques such as digital PCR, NGS and bioinformatics to build in vitro diagnostic tests for the medical and clinical community.

1 investor

CHA Biotech is a South Korean biotechnology company operating in areas including cord blood banking, cell insurance, genomics, CDMO manufacturing, and healthcare consulting. It also runs related businesses such as the Chaum health center and IT services.

1 investor